$ISCO
International Stem Cell CORP

2018 Q4 Form 10-Q Financial Statement

#000156459018029577 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $2.223M $3.195M $1.850M
YoY Change 20.82% 72.7% -4.64%
Cost Of Revenue $834.0K $1.315M $470.0K
YoY Change 34.52% 179.79% -22.95%
Gross Profit $1.389M $1.880M $1.370M
YoY Change 13.85% 37.23% 2.24%
Gross Profit Margin 62.48% 58.84% 74.05%
Selling, General & Admin $2.100M $1.927M $1.640M
YoY Change -16.0% 17.5% -13.23%
% of Gross Profit 151.19% 102.5% 119.71%
Research & Development $517.0K $616.0K $670.0K
YoY Change -13.83% -8.06% -1.47%
% of Gross Profit 37.22% 32.77% 48.91%
Depreciation & Amortization $93.00K $45.00K $48.00K
YoY Change 16.25% -6.25% -5.88%
% of Gross Profit 6.7% 2.39% 3.5%
Operating Expenses $2.649M $2.543M $2.350M
YoY Change -15.9% 8.21% -9.62%
Operating Profit -$1.260M -$663.0K -$980.0K
YoY Change -34.72% -32.35% -22.22%
Interest Expense $254.0K $17.00K -$1.190M
YoY Change -52.96% -101.43% -170.83%
% of Operating Profit
Other Income/Expense, Net -$22.00K $43.00K $0.00
YoY Change
Pretax Income -$1.028M $121.0K -$2.160M
YoY Change -26.04% -105.6% -626.83%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$1.028M $121.0K -$2.160M
YoY Change -26.04% -105.6% -626.83%
Net Earnings / Revenue -46.24% 3.79% -116.76%
Basic Earnings Per Share
Diluted Earnings Per Share -$150.0K $18.89K -$537.3K
COMMON SHARES
Basic Shares Outstanding 6.771M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.080M $595.0K $510.0K
YoY Change 260.0% 16.67% -30.14%
Cash & Equivalents $1.075M $1.161M $510.0K
Short-Term Investments
Other Short-Term Assets $540.0K $440.0K $590.0K
YoY Change -30.77% -25.42% 11.32%
Inventory $1.501M $1.317M $1.350M
Prepaid Expenses
Receivables $651.0K $976.0K $680.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.770M $3.328M $3.130M
YoY Change 32.05% 6.33% -0.32%
LONG-TERM ASSETS
Property, Plant & Equipment $469.0K $347.0K $340.0K
YoY Change 46.11% 2.06% -17.07%
Goodwill
YoY Change
Intangibles $2.674M $2.848M
YoY Change -8.49%
Long-Term Investments
YoY Change
Other Assets $880.0K $877.0K $780.0K
YoY Change 14.29% 12.44% 30.0%
Total Long-Term Assets $4.026M $5.213M $4.820M
YoY Change 0.42% 8.15% 9.55%
TOTAL ASSETS
Total Short-Term Assets $3.770M $3.328M $3.130M
Total Long-Term Assets $4.026M $5.213M $4.820M
Total Assets $7.796M $8.541M $7.950M
YoY Change 13.58% 7.43% 5.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $458.0K $731.0K $850.0K
YoY Change -44.82% -14.0% 6.25%
Accrued Expenses $579.0K $813.0K $620.0K
YoY Change -4.61% 31.13% 0.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.077M $4.458M $8.140M
YoY Change 5.77% -45.23% 14.33%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $180.0K $974.0K
YoY Change
Total Long-Term Liabilities $180.0K $974.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.077M $4.458M $8.140M
Total Long-Term Liabilities $180.0K $974.0K $0.00
Total Liabilities $5.259M $5.432M $8.140M
YoY Change 9.56% -33.27% 14.33%
SHAREHOLDERS EQUITY
Retained Earnings -$106.7M
YoY Change 2.04%
Common Stock $7.000K
YoY Change 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.537M $2.786M -$190.0K
YoY Change
Total Liabilities & Shareholders Equity $7.796M $8.541M $7.950M
YoY Change 13.58% 7.43% 5.44%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$1.028M $121.0K -$2.160M
YoY Change -26.04% -105.6% -626.83%
Depreciation, Depletion And Amortization $93.00K $45.00K $48.00K
YoY Change 16.25% -6.25% -5.88%
Cash From Operating Activities $34.00K -$556.0K -$320.0K
YoY Change -106.94% 73.75% -25.58%
INVESTING ACTIVITIES
Capital Expenditures -$132.0K -$129.0K -$170.0K
YoY Change -37.14% -24.12% -26.09%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$132.0K -$129.0K -$170.0K
YoY Change -37.14% -24.12% -26.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.00K 1.372M 700.0K
YoY Change -97.6% 96.0% 12.9%
NET CHANGE
Cash From Operating Activities 34.00K -556.0K -320.0K
Cash From Investing Activities -132.0K -129.0K -170.0K
Cash From Financing Activities 12.00K 1.372M 700.0K
Net Change In Cash -86.00K 687.0K 210.0K
YoY Change -57.0% 227.14% -625.0%
FREE CASH FLOW
Cash From Operating Activities $34.00K -$556.0K -$320.0K
Capital Expenditures -$132.0K -$129.0K -$170.0K
Free Cash Flow $166.0K -$427.0K -$150.0K
YoY Change -159.29% 184.67% -25.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8866000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5614000
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
465000
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
2848000
CY2017Q4 isco Deposits And Other Assets
DepositsAndOtherAssets
74000
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6771425
CY2018Q3 us-gaap Cash
Cash
1161000
CY2017Q4 us-gaap Cash
Cash
304000
CY2017Q4 us-gaap Inventory Net
InventoryNet
1307000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
779000
CY2018Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
774000
CY2017Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
692000
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
347000
CY2017Q4 us-gaap Assets
Assets
6864000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
830000
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
607000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1165000
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3300000
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
49000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000
CY2017 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2756000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1384000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-6069000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
500000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
145000
us-gaap Profit Loss
ProfitLoss
-1103000
us-gaap Profit Loss
ProfitLoss
-4680000
isco Gain Loss On Settlement Of Trade Payable
GainLossOnSettlementOfTradePayable
32000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
25000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1116000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1649000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
372000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-529000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-651000
isco Proceeds From Bridge Loan From Related Party
ProceedsFromBridgeLoanFromRelatedParty
2000000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
500000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145000
isco Payments On Financed Insurance Premiums
PaymentsOnFinancedInsurancePremiums
143000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2502000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2700000
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
857000
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
400000
CY2016Q4 us-gaap Cash
Cash
110000
CY2017Q3 us-gaap Cash
Cash
510000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values, allowance for excess and obsolete inventories, allowance for sales returns and doubtful accounts, and transactions using the Black-Scholes option pricing model, e.g., warrants and stock options, as well as the Monte-Carlo valuation method for certain warrants. Actual results could differ from those estimates. </p></div>
CY2018Q3 isco Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
2248000
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
236000
CY2018Q3 isco Percentage Of Ownership In Issue And Outstanding Share Of Common Stock Parent Company
PercentageOfOwnershipInIssueAndOutstandingShareOfCommonStockParentCompany
0.937
CY2006Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
133334
isco Burn Rate Excluding Capital Expenditures And Patent Costs
BurnRateExcludingCapitalExpendituresAndPatentCosts
124000
isco Capital Expenditures And Patent Costs
CapitalExpendituresAndPatentCosts
59000
isco Revenue Generating Subsidiaries
RevenueGeneratingSubsidiaries
2
isco Maximum Original Maturities Period
MaximumOriginalMaturitiesPeriod
P3M
CY2018Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3774000
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3763000
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
926000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
841000
CY2018Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
157000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
The Company's revenue consists primarily of sales of products from its two revenue-generating operating segments, the cosmetics products and biomedical products business segments. The cosmetic market segment markets and sells a line of luxury skincare products sold through three sales channels: ecommerce, professional, and international. The ecommerce channel sells direct to customers through online orders, while the professional sales are to spas, salons and other skincare providers. International sales are primarily through distributors. The biomedical market segment markets and sells primary human cell research products with two product categories, cells and media, sold both within and outside the United States.
CY2018Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1570227
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
828773
CY2018Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2922462
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1508166
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3951052
CY2017Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4001469
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
698000
CY2017Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
609000
CY2018Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
572000
CY2017Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
472000
CY2018Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1276000
CY2017Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1154000
CY2018Q3 us-gaap Inventory Gross
InventoryGross
2546000
CY2017Q4 us-gaap Inventory Gross
InventoryGross
2235000
CY2018Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
298000
CY2017Q4 isco Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
1999000
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3063000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2907000
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2716000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2586000
CY2018Q3 us-gaap Depreciation
Depreciation
45000
us-gaap Depreciation
Depreciation
130000
CY2017Q3 us-gaap Depreciation
Depreciation
48000
us-gaap Depreciation
Depreciation
146000
CY2018Q3 isco Finite Lived Patents And Trademarks Gross
FiniteLivedPatentsAndTrademarksGross
3027000
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
32000
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
94000
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
77000
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
77000
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
98000
CY2018Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2384000
CY2018Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2762000
CY2008Q2 isco Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
250000
CY2008Q2 isco Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
250000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2008Q2 isco Number Of Accredited Investors
NumberOfAccreditedInvestors
5
CY2018Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
500000
CY2018Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.75
isco Related Party Rent Expense
RelatedPartyRentExpense
120000
isco Related Party Rent Expense
RelatedPartyRentExpense
116000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 isco Net Decrease In Deferred Tax Assets
NetDecreaseInDeferredTaxAssets
8819000
CY2017 isco Increase In Deferred Tax Assets
IncreaseInDeferredTaxAssets
724000
CY2017 isco Tax Cuts And Jobs Act Of2017 Change In Tax Rate Decrease In Deferred Tax Assets
TaxCutsAndJobsActOf2017ChangeInTaxRateDecreaseInDeferredTaxAssets
9543000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1010000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
67500
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
33750
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
30.00
CY2013Q1 isco Warrant Term
WarrantTerm
P5Y
invest Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
2018-01-31
CY2013Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
16667
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
33334
CY2013Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
30.00
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7321468
CY2017 isco Warrant Forfeited Or Cancelled
WarrantForfeitedOrCancelled
3319999
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4001469
isco Warrant Forfeited Or Cancelled
WarrantForfeitedOrCancelled
50417
CY2017 isco Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Forfeited
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsForfeited
1.75
isco Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Forfeited
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsForfeited
30.00
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.75
CY2018Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
88000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
264000
CY2017Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
87000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
258000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
95000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
491000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
368000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
347000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
220000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
461000
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1982000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
isco Number Of Business Units
NumberOfBusinessUnits
2
isco Number Of Products
NumberOfProducts
203

Files In Submission

Name View Source Status
0001564590-18-029577-index-headers.html Edgar Link pending
0001564590-18-029577-index.html Edgar Link pending
0001564590-18-029577.txt Edgar Link pending
0001564590-18-029577-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isco-10q_20180930.htm Edgar Link pending
isco-20180930.xml Edgar Link completed
isco-20180930.xsd Edgar Link pending
isco-20180930_cal.xml Edgar Link unprocessable
isco-20180930_def.xml Edgar Link unprocessable
isco-20180930_lab.xml Edgar Link unprocessable
isco-20180930_pre.xml Edgar Link unprocessable
isco-ex311_7.htm Edgar Link pending
isco-ex312_6.htm Edgar Link pending
isco-ex321_8.htm Edgar Link pending
isco-ex322_10.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending